Skip to main navigation Skip to search Skip to main content

Angiostatin 4.5

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

For tumors to grow and metastasize, they must induce the generation of new blood vessels, a process referred to as angiogenesis. Angiogenesis begins when a fibrin clot forms on the external surface of an existing blood vessel, followed by growing of new capillaries. The initial phase begins with increased vascular permeability and local degradation of the vessel wall. The endothelial cells enter the tumor stroma, migrate toward a stimulus such as VEGF or FGF, and proliferate behind the leading edge. At this time, the cells may be most vulnerable to agents that interfere with their proliferation, since they lack protection from other cell types. The next step in vessel formation is recruitment of pericytes, followed by smooth muscle cells. Inhibition of angiogenesis thus provides an important new therapeutic target. The angiogenesis inhibitor angiostatin is a kringle-containing internal fragment of plasminogen, which inhibits cancer growth in numerous animal models .... © 2008

Original languageEnglish
Title of host publicationxPharm
Subtitle of host publicationThe Comprehensive Pharmacology Reference
PublisherElsevier Inc.
Pages1-4
Number of pages4
ISBN (Print)9780080552323
DOIs
StatePublished - 2008
Externally publishedYes

ASJC Scopus Subject Areas

  • General Pharmacology, Toxicology and Pharmaceutics

Disciplines

  • Medicine and Health Sciences

Fingerprint

Dive into the research topics of 'Angiostatin 4.5'. Together they form a unique fingerprint.

Cite this